T1	PROC 46 75	Estudio multicéntrico abierto
T2	PROC 81 112	evaluar la seguridad y eficacia
T3	PROC 134 162	tratamiento de mantenimiento
#1	AnnotatorNotes T3	C0677908; Maintenance therapy; Therapeutic or Preventive Procedure
T4	DISO 169 188	psoriasis en placas
#2	AnnotatorNotes T4	C0263361; Psoriasis vulgaris; Disease or Syndrome
T5	PROC 231 252	Estudio multicéntrico
#3	AnnotatorNotes T5	C1096776; Multicenter Study; Research Activity
T6	PROC 266 300	evaluar la seguridad y la eficacia
#4	AnnotatorNotes T6	C0511730; Identify product efficacy and safety issues; Health Care Activity
T7	PROC 322 350	tratamiento de mantenimiento
#5	AnnotatorNotes T7	C0677908; Maintenance therapy; Therapeutic or Preventive Procedure
T8	DISO 357 376	psoriasis en placas
#6	AnnotatorNotes T8	C0263361; Psoriasis vulgaris; Disease or Syndrome
T9	DISO 437 446	psoriasis
#7	AnnotatorNotes T9	C0033860; Psoriasis; Disease or Syndrome
T10	DISO 454 477	enfermedad inflamatoria
T11	ANAT 487 501	Sistema inmune
#8	AnnotatorNotes T11	C0020962; Immune system; Body System | C1305754; Entire immune system; Body System
T12	ANAT 513 517	piel
#9	AnnotatorNotes T12	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T13	ANAT 541 550	escamosos
#10	AnnotatorNotes T13	C0221909; Squamous epithelium; Tissue
T14	ANAT 563 567	piel
#11	AnnotatorNotes T14	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T15	DISO 595 604	Psoriasis
#12	AnnotatorNotes T15	C0033860; Psoriasis; Disease or Syndrome
T16	DISO 654 681	psoriasis en placas crónica
T17	CHEM 116 128	risankizumab
#13	AnnotatorNotes T17	C4505511; risankizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T18	CHEM 878 890	risankizumab
#14	AnnotatorNotes T18	C4505511; risankizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T19	PROC 843 873	tratamiento abierto prolongado
T20	CHEM 304 316	risankizumab
#15	AnnotatorNotes T20	C4505511; risankizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T21	DISO 533 567	parches escamosos rojos en la piel
T22	Date 13 17	2016
T25	LIVB 634 649	Sujetos adultos
#16	AnnotatorNotes T25	C0681850; Study Subject; Group + C0001675; Adult; Age Group
T26	Duration 674 681	crónica
#17	AnnotatorNotes T26	C0205191; chronic; Temporal Concept
T27	LIVB 806 813	sujetos
#18	AnnotatorNotes T27	C0681850; Study Subject; Group
T28	LIVB 911 923	investigador
#19	AnnotatorNotes T28	C0035173; Research Personnel; Professional or Occupational Group
A1	Population_data T25 Age
#20	AnnotatorNotes T1	C1096776; Multicenter Study; Research Activity + C1709323; Open Label Study; Research Activity 
#21	AnnotatorNotes T2	C0511730; Identify product efficacy and safety issues; Health Care Activity
#22	AnnotatorNotes T10	C1290884; Inflammatory disorder; Disease or Syndrome 
R1	Used_for Arg1:T17 Arg2:T3	
T23	Quantifier_or_Qualifier 192 208	moderada a grave
#23	AnnotatorNotes T23	C1299393; Moderate to severe; Qualitative Concept
R2	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T23	
T24	Quantifier_or_Qualifier 380 396	moderada a grave
R3	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T24	
R5	Location_of Arg1:T12 Arg2:T10	
R6	Location_of Arg1:T12 Arg2:T9	
R4	Location_of Arg1:T14 Arg2:T21	
R7	Location_of Arg1:T12 Arg2:T21	
R8	Location_of Arg1:T14 Arg2:T10	
R9	Location_of Arg1:T14 Arg2:T9	
R10	Causes Arg1:T9 Arg2:T21	
R11	Experiences Arg1:T25 Arg2:T16	
R12	Has_Duration_or_Interval Arg1:T16 Arg2:T26	
T29	Quantifier_or_Qualifier 685 701	moderada a grave
#24	AnnotatorNotes T24	C1299393; Moderate to severe; Qualitative Concept
#25	AnnotatorNotes T29	C1299393; Moderate to severe; Qualitative Concept
R13	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T29	
T30	Observation 712 742	completado uno de los estudios
A2	Status T30 History_of
R14	Experiences Arg1:T27 Arg2:T19	
R15	Used_for Arg1:T18 Arg2:T19	
T31	Observation 954 979	Discontinuación prematura
#26	AnnotatorNotes T31	C0422727; Patient withdrawn from trial; Finding (?)
T32	PROC 1006 1013	estudio
A3	Status T32 History_of
#27	AnnotatorNotes T32	C0008976; Clinical Trials; Research Activity
R16	Overlap Arg1:T31 Arg2:T32	
R17	Used_for Arg1:T20 Arg2:T7	
T33	Quantifier_or_Qualifier 518 522	sana
#28	AnnotatorNotes T33	C3898900; Healthy; Qualitative Concept
R18	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T33	
#29	AnnotatorNotes T30	C2732579; Completion of clinical trial; Finding
A4	Experiencer T25 Patient
A5	Experiencer T27 Patient
A6	Experiencer T28 Other
A7	Status T18 Future
A8	Status T19 Future
